These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 4142471)

  • 1. Demonstration of Epstein-Barr virus-associated nuclear antigen in nasopharyngeal carcinoma cells from fresh biopsies.
    Huang DP; Ho JH; Henle W; Henle G
    Int J Cancer; 1974 Nov; 14(5):580-8. PubMed ID: 4142471
    [No Abstract]   [Full Text] [Related]  

  • 2. Presence of Epstein-Barr virus nuclear antigen in nasopharyngeal carcinoma biopsies and their derived cultures.
    de-Thé G; Ablashi DV; Favre MC; Mourali N; Ellouz R
    Bibl Haematol; 1975; (40):101-3. PubMed ID: 169807
    [No Abstract]   [Full Text] [Related]  

  • 3. Epstein-Barr virus-associated complement-fixing and nuclear antigens in Burkitt lymphoma biopsies.
    Reedman BM; Klein G; Pope JH; Walters MK; Hilgers J; Singh S; Johansson B
    Int J Cancer; 1974 Jun; 13(6):755-63. PubMed ID: 4136722
    [No Abstract]   [Full Text] [Related]  

  • 4. Detection of Epstein-Barr virus antigens and antibodies by peroxidase-labeled specific immunoglobulins.
    Kurstak E; de Thé G; van den Hurk J; Charpentier G; Kurstak C; Tijssen P; Morisset R
    J Med Virol; 1978; 2(3):189-200. PubMed ID: 212523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation between early and late membrane antigen on human lymphoblastoid cell lines infected with Epstein-Barr virus. I. Immunofluorescence.
    Ernberg I; Klein G; Kourilsky FM; Silvestre D
    J Natl Cancer Inst; 1974 Jul; 53(1):61-5. PubMed ID: 4365906
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection of the EBV-determined nuclear antigen (EBNA) in Burkitt's lymphoma and nasopharyngeal carcinoma biopsies by the acid fixed nuclear binding (AFNB) technique.
    Luka J; Klein G; Henle W; Henle G
    Cancer Lett; 1978 Apr; 4(4):199-205. PubMed ID: 206349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epstein-Barr virus induces viral nuclear antigen in nasopharyngeal epithelial cells.
    Desgranges C; de-Thé G
    Lancet; 1977 Dec; 2(8051):1286-7. PubMed ID: 73981
    [No Abstract]   [Full Text] [Related]  

  • 8. The rescue of Epstein--Barr virus from primary cultured cells of nasopharyngeal carcinoma.
    Takada M; Murata M; Takei M; Nakagawa S; Okumura H; Kawamura A
    Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):177-89. PubMed ID: 228891
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytotoxic antibodies to cultured lymphoblasts unrelated to Epstein-Barr virus.
    Yang CS; Hewetson JF
    Int J Cancer; 1974 Oct; 14(4):530-8. PubMed ID: 4376526
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the Epstein-Barr Virus genome and the EBV-determined nuclear antigen in human malignant disease.
    Klein G
    Cold Spring Harb Symp Quant Biol; 1975; 39 Pt 2():783-90. PubMed ID: 169032
    [No Abstract]   [Full Text] [Related]  

  • 11. Epstein-Barr virus-determined nuclear antigen in malignant epithelial cells of nasopharyngeal carcinoma.
    Suzuki T; Katano A; Oboshi S; Sairenji T; Hinuma Y
    Gan; 1978 Feb; 69(1):133-8. PubMed ID: 205477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A specific histological marker of undifferentiated carcinoma of the nasopharynx. The ACIF (Anti-Complement Immunofluorescence) test].
    Micheau C; De The G; Schwaab G; Tursz T; Sancho-Garnier H; Montagu B
    Ann Pathol; 1984; 4(2):143-6. PubMed ID: 6329239
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on Epstein-Barr virus-associated antigens.
    Ernberg I
    Ann N Y Acad Sci; 1975 Jun; 254():516-22. PubMed ID: 170849
    [No Abstract]   [Full Text] [Related]  

  • 14. Early events in transformation of human cord leukobytes by Epstain-Barr virus: induction of DNA synthesis, mitosis and the virus-associated nuclear antigen synthesis.
    Aya T; Osato T
    Int J Cancer; 1974 Sep; 14(3):341-7. PubMed ID: 4376517
    [No Abstract]   [Full Text] [Related]  

  • 15. Discordant Epstein-Barr virus nuclear antigen (EBNA) antibody patterns in nasopharyngeal carcinoma.
    Hewetson JF; Levine PH; Neubauer RH; Rabin H
    Int J Cancer; 1982 Nov; 30(5):581-5. PubMed ID: 6295966
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus (EBV) antigenic determinants on subunits of the EBV determined nuclear antigen (EBNA).
    Hentzen D; Lenoir GM; Berthelon MC; Daillie J
    Biochem Biophys Res Commun; 1980 Sep; 96(1):425-32. PubMed ID: 6159888
    [No Abstract]   [Full Text] [Related]  

  • 17. Epstein-Barr virus-associated antigens activated in human cells by 5-bromodeoxyuridine.
    Gerber P; Lucas S
    Proc Soc Exp Biol Med; 1972 Nov; 141(2):431-8. PubMed ID: 4344263
    [No Abstract]   [Full Text] [Related]  

  • 18. Specific neutralizing antibodies in Epstein-Barr virus associated diseases.
    Rocchi G; Hewetson J; Henle W
    Int J Cancer; 1973 May; 11(3):637-47. PubMed ID: 4364719
    [No Abstract]   [Full Text] [Related]  

  • 19. In situ detection of Epstein-Barr virus markers in nasopharyngeal carcinoma patients.
    Lung ML; Chan KH; Lam WP; Kou SK; Choy D; Chan CW; Ng MH
    Oncology; 1989; 46(5):310-7. PubMed ID: 2550863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence for a relation of Epstein-Barr virus to Burkitt's lymphoma and nasopharyngeal carcinoma.
    Henle W; Henle G
    Bibl Haematol; 1970; (36):706-13. PubMed ID: 4376392
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.